Androgen receptor and ALDH1 expression among internationally diverse patient populations

Evelyn Jiagge, Aisha Souleiman Jibril, Melissa Davis, Carlos Murga-Zamalloa, Celina G. Kleer, Kofi Gyan, George Divine, Mark Hoenerhoff, Jessica Bensenhave, Baffour Awuah, Joseph Oppong, Ernest Adjei, Barbara Salem, Kathy Toy, Sofia Merajver, Max Wicha, Lisa Newman

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Purpose Population-based incidence rates of breast cancers that are negative for estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2/neu (triple-negative breast cancer [TNBC]) are higher among African American (AA) compared with white American (WA) women, and TNBC prevalence is elevated among selected populations of African patients. The extent to which TNBC risk is related to East African versus West African ancestry, and whether these associations extend to expression of other biomarkers, is uncertain. Methods We used immunohistochemistry to evaluate estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2/neu, androgen receptor and aldehyde dehydrogenase 1 (ALDH1) expression among WA (n = 153), AA (n = 76), Ethiopian (Eth)/East African (n = 90), and Ghanaian (Gh)/West African (n = 286) patients with breast cancer through an institutional review board-approved international research program. Results Mean age at diagnosis was 43, 49, 60, and 57 years for the Eth, Gh, AA, and WA patients, respectively. TNBC frequency was higher for AA and Gh patients (41% and 54%, respectively) compared with WA and Eth patients (23% and 15%, respectively; P < .001) Frequency of ALDH1 positivity was higher for AA and Gh patients (32% and 36%, respectively) compared with WA and Eth patients (23% and 17%, respectively; P = .007). Significant differences were observed for distribution of androgen receptor positivity: 71%, 55%, 42%, and 50% for the WA, AA, Gh, and Eth patients, respectively (P = .008). Conclusion Extent of African ancestry seems to be associated with particular breast cancer phenotypes. West African ancestry correlates with increased risk of TNBC and breast cancers that are positive for ALDH1.

Original languageEnglish (US)
JournalJournal of Global Oncology
Volume2018
Issue number4
DOIs
StatePublished - Mar 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Androgen receptor and ALDH1 expression among internationally diverse patient populations'. Together they form a unique fingerprint.

  • Cite this

    Jiagge, E., Jibril, A. S., Davis, M., Murga-Zamalloa, C., Kleer, C. G., Gyan, K., Divine, G., Hoenerhoff, M., Bensenhave, J., Awuah, B., Oppong, J., Adjei, E., Salem, B., Toy, K., Merajver, S., Wicha, M., & Newman, L. (2018). Androgen receptor and ALDH1 expression among internationally diverse patient populations. Journal of Global Oncology, 2018(4). https://doi.org/10.1200/JGO.18.00056